Meet Javier Lopez, A Friendly Rectal Microbicide Advocate

Check out Javier Lopez's mini-bio, the latest in IRMA's "Meet a Friendly Rectal Microbicide Advocate" series on the IRMA website here.  Javier is one of five new bios posted this week.

 

Javier Lopez

New York City, USA

Javier Lopez first learned about rectal microbicides when his partner worked for Project Gel in Puerto Rico. Javier was immediately impressed by the creativity of this approach to HIV prevention as promotion of condoms alone is often difficult in all populations.

Soon after, he attended a talk on rectal microbicides by IRMA's Jim Pickett at Gay Men's Health Crisis (GMHC) in New York City. Then he was hooked and snatched up a few "Rectal Pride" stickers that now fabulously adorn his Ipad cover.

Javier has long been an advocate for HIV testing and for years has been involved in the HIV prevention fight in Puerto Rico. During his undergraduate studies he took part in numerous educational sessions for HIV/STI prevention in gay men. Currently, Javier is working as an assistant research scientist at the HIV Center for Clinical and Behavioral Studies that seeks to improve intervention screening practices for acute HIV infection in primary care setting in New York City. Soon Javier will be taking his education further as he enters the Masters of Public Health program at Hunter College in New York City.

Javier is also proud to have been a part of the recently launched HIV testing campaign for the CDC called "Reasons/Razones" which targets Latino gay and bisexual men to consider their reasons for getting tested. More information about this exciting campaign is available here.

Javier is excited to be a rectal microbicide advocate because he believes that it is important for this research to continue and that youth of all backgrounds should get involved.

Thank you Javier!

 

------------------- *Join IRMA's robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,100 advocates, scientists, policy makers and funders from all over the world.

*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.

*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article's content. -------------------

Give Some LOVE to IRMA for Give OUT Day

Condoms are getting some help! 

Dear IRMA members and readers of this blog -

Give OUT Day shines a spotlight on organizations that empower LGBTQ communities across the country, and the AIDS Foundation of Chicago (AFC) is among these charities.

We’re using this campaign to highlight the next generation of HIV prevention: rectal microbicides. Though they’re still in development, these agents can be added to things like lubricants that will prevent the transmission of HIV, revolutionizing the way we protect ourselves and others. Condoms are getting some help!

This will greatly benefit gay and bisexual men, transgender individuals, and women because rectal microbicides are developed specifically for anal intercourse—a common human behavior. We need to expand the ways we protect ourselves against HIV, and rectal microbicides are quite promising. With the support of AFC’s global advocacy initiative—International Rectal Microbicide Advocates—scientists have achieved an enormous amount of progress, and we’re tremendously excited about the future.

You have an opportunity to support advocacy efforts that will be instrumental in making rectal microbicides a reality for all who need them.

Learn more by downloading this podcast on rectal microbicides, and visit our Give OUT page to make a contribution today.

Thanks,
Jim Pickett
Chair, International Rectal Microbicide Advocates


-------------------

*Join IRMA's robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,200 advocates, scientists, policy makers and funders from all over the world.

*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.

*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article's content.

-------------------

VIDEO: IRMA's Jim Pickett - Condoms Not Enough in HIV Fight

"Using condoms for your entire sexual life works for some people. And for others, it doesn't." 

Video via Be The Generation

IRMA chair Jim Pickett discusses the need for new ways to prevent HIV, like rectal microbicides.


-------------------

 *Join IRMA's robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,200 advocates, scientists, policy makers and funders from all over the world.

*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.

 *Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article's content.

-------------------

VIDEO: POZ on Location Captures 4 HOT Minutes on Rectal Microbicide Research

"The Bottom Line on Rectal Microbicide Research" was presented by IRMA's Jim Pickett at Gay Men's Health Crisis in NYC on January 23, 2013. POZ Magazine recorded the proceedings and produced this 4-minute highlight video, below. Check it out!

Click here to download Jim's presentation slides.

"The Rectal Revolution is Here" was screened as well. You can watch the 14-minute video describing rectal microbicide clinical trials on YouTube in English, Spanish, or Thai. It's an entertaining mix of live action and animation, and features a rectal microbicide trial participant who explains what the process was like, and why he chose to be in a prevention trial.

-------------------

  *Join IRMA's robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,100 advocates, scientists, policy makers and funders from all over the world.

*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.

*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article's content.

  -------------------

GMHC presents: The Bottom Line on Rectal Microbicide Research - 1/23/13 in NYC

You are invited to a discussion and video presentation on rectal microbicide research and advocacy with IRMA and friends at Gay Men's Health Crisis in NYC, from 10am til noon on Wednesday, January 23, 2013.

View a special screening of the new video "The Rectal Revolution is Here: An introduction to rectal microbicide clinical trials."

Light refreshments will be provided. Event is FREE and open to the public.

For more details, click here for the fyer. Or click on the image below.

Click image to enlarge.

-------------------

*Join IRMA's robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,100 advocates, scientists, policy makers and funders from all over the world.

*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.

  *Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article's content.

  -------------------

Rectal microbicide research gives hope for HIV protection

via Citizens News Service, by Somya Arora

According to the Microbicides Trials Network (MTN), HIV continues to disproportionately affect racial minorities and men who have sex with men (MSM). MTN estimates that 5 to 10 percent of the world’s population engages in anal sex and globally, MSM are 19 times more likely to be infected with HIV than the general population. Unprotected anal sex is the primary driver of the HIV epidemic among this population. The risk of becoming infected with HIV during unprotected anal sex is 10 to 20 times greater than unprotected vaginal sex, because the rectal lining being only one-cell thick, it allows the virus to easily reach immune cells to infect. 

“Rectal microbicides are critical to turn the tide of the AIDS pandemic as we know that unprotected anal intercourse is the riskiest of HIV related behaviours. Human beings, all over the world, regardless of gender and sexuality, have anal intercourse and a lot of this is unprotected because they do not have access to condoms and/or because of the mistaken notion that anal intercourse is safer than vaginal intercourse with regards to contracting HIV. Having more tools for protection, in addition to what we already have, I think would be absolutely critical,” says Jim Pickett, Director (Advocacy), Chicago AIDS Foundation and founder-chair of International Rectal Microbicide Advocates (IRMA).

In an update on the CHARM (Combination HIV Antiretroviral Rectal Microbicide) Program, Dr Ian McGowan, Professor of Medicine, University of Pittsburgh, and Co-principal Investigator MTN, informs that, “Microbicides are products that can be applied to the vaginal or rectal mucosa with the intent of preventing or significantly reducing the risk of acquiring Sexually Transmitted Infections including HIV. Combination antiretrovirals are more potent and more useful as rectal microbicides. The rationale behind the CHARM programme is that we need a rectal specific combination antiretroviral microbicide.”

Read the rest.


-------------------

*Join IRMA's robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,100 advocates, scientists, policy makers and funders from all over the world.

*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.

*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article's content.

-------------------

[VIDEO] McGowan and Pickett Talk the Rectal Microbicide Walk at Microbicides 2012

Rectal microbicides were ALL OVER the Microbicides 2012 conference...

Chatting up rectal microbicide research and advocacy activities and issues at the recent Microbicides 2012 conference (held in Sydney this past April) were Dr. Ian McGowan, co-principal investigator of the Microbicide Trials Network (and IRMA Scientific Co-Chair) and IRMA Chair Jim Pickett.

Have a look/listen to their discussion with reporters.

 

*Check out pics from the Microbicides 2012 conference on IRMA's Facebook page.

-------------------

*Join IRMA's robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,100 advocates, scientists, policy makers and funders from all over the world.

*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article's content.

-------------------

 

Critical to fight stigma and discrimination faced by MSM

via Inside Story, by Gregory Trotter

The dream of the AIDS-free generation will never be realized as long as there remain countries in the world that kill and imprison people for being gay.

Same goes for countries that won’t even acknowledge homosexuality exists within their national boundaries and therefore fail to provide targeted HIV prevention and treatment services. Such are the realities underscored by a new report, “Achieving an AIDS-free Generation for Gay Men and Other MSM,” released by amfAR and Johns Hopkins University on Wednesday.

The report studied the funding and implementation of HIV services targeted for MSM (men who have sex with men) in eight countries where same-sex intercourse is criminalized or heavily stigmatized: China, Vietnam, Ethiopia, Guyana, Mozambique, India, Nigeria and Ukraine. Among other findings, the study concluded that MSM are “deprioritized and marginalized by national HIV programs.”

In the report’s own words: “It will be impossible to achieve an ‘AIDS-Free Generation’ if MSM are left behind.”

(For those who may not know, the phrase “AIDS-free generation” has been a sort of battle cry for people and organizations involved in the ongoing efforts to stop the 30-year-old AIDS epidemic, gaining momentum since Secretary of State Hillary Clinton used it in her historic November 2011 speech.)

The report rings true for Jim Pickett, director of prevention advocacy and gay men’s health for the AIDS Foundation of Chicago (AFC). Pickett is also chair of the International Rectal Microbicides Advocates, a group that does what its name suggests. His work takes him all over the world to advocate for microbicide research and other HIV prevention strategies.

“Sadly, it’s not new. It’s what we know. But … it’s really important for us to continue to put that message out there. It’s another way to have this discussion, to shine a light on these disparities and to move forward in the right direction,” Pickett said. “(This report) is a really important document.”
Pickett was in Addis Ababa, Ethiopia, just last month for a meeting with advocates for the launch of Project ARM (stands for Africa for Rectal Microbicides). Project ARM is an IRMA initiative. The conference coincided with the 2011 International Conference on AIDS and STDs in Africa.

It was wrought with tension from the get-go, as anti-gay religious groups caught wind of an African gay men’s health pre-conference satellite and began mounting a protest. Eventually, they were silenced by the Ethiopian government, Pickett said. But it was an uncomfortable learning experience: IRMA and Project ARM kept their own agendas low-profile and encountered no problems.

At the Project ARM meeting, advocates from Malawi, Uganda and other countries talked about the fear of being discovered gay after receiving threats of bodily harm and death.

“We acknowledge that in our quest for developing these new HIV prevention strategies like rectal microbicides, they are for naught if people aren’t safe, if they can’t be who they are wherever they are,” Pickett said. “If you are so deeply stigmatized or demonized that you have to be hidden, you’re not going to come up and go to the counter and get a rectal microbicide. You’re not going to get any services.”

As an example, Pickett pointed to the arrests of nine gay men in Senegal following the 2008 ICASA. Word quickly rippled through the gay community in Senegal.

Read the rest.



[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]

Project ARM - Africa for Rectal Microbicides - Strategy Meeting a Success!

Originally published by IRMA colleagues at Mapping Pathways here.

“It was an amazing group, and one that moved me to near tears on a number of occasions”

IRMA chairman Jim Pickett just returned from an inspiring week in Addis Ababa, Ethiopia, where he led a strategy meeting for the  IRMA's Project ARM - Africa for Rectal Microbicides - and then attended the ICASA 2011 conference (read more about both here and here). We checked in with Jim for an update on IRMA's Project on the meeting held December 2nd and 3rd.

The meeting, which was the result of 18 months of planning and coordination, convened about 40 individuals - both invited speakers and guests, including 16 individuals who secured scholarships to attend (out of 145 applicants.) The meeting participants represented countries including Ethiopia, Rwanda, Cameroon, Kenya, Nigeria, Zambia, Malawi, Zimbabwe, South Africa, Uganda, Canada, United Kingdom, and the United States -researchers, advocates, LGBT people, heterosexual people, and those representing sex workers, prison populations and more.

“It was an amazing group, and one that moved me to near tears on a number of occasions,” says Pickett, who explained that the aim of this meeting was for people to come together and create a strategy, a road map, around rectal microbicide research and advocacy specific to the African context. “I've been to many, many meetings – too many – in my day and I think the Project ARM meeting was, by far, one of the most productive, inspiring, exciting, energizing, and emotionally moving ones I've ever had the privilege to attend. Yes, I am obviously biased - but it isn't often that events like these make me misty-eyed and put a lump in my throat – repeatedly.”

The journey to getting all these people together for this meeting was not easy, as many faced multiple challenges securing the required visas for travel to Ethiopia. Says Pickett, “There was this incredible energy in the room. We’d been planning this meeting for the past 18 months, and it has been a long journey for all of us to make this happen. A number of the people attending went to extraordinary lengths to get to Addis Ababa. They had to make so many trips to embassies and consulates for visas, so many obstacles were placed in their way to dissuade them from attending, but none of them took no for an answer. The incredible perseverance they exhibited simply to show up was extremely moving.”

The participants spent the two days together getting informed – including sharing the latest updates on rectal microbicide science, rectal microbicide advocacy, issues around LGBT crimininalization, anal sex prevalence, the gay/MSM epidemic, and more. “But we didn't just passively listen to others speak - we broke out into small groups a number of times to unpack what we learned and to come up with priorities and plans for moving forward,” says Pickett.

Four advocacy-focused items and four research-focused items were prioritized, and action steps were developed for each. These included expanded rectal microbicide scientific research activities in Africa, expanded research into anal sex behaviors among African straight and gay/MSM populations, communication/education efforts, and the birth of the Global Lube Access Mobilization (GLAM) campaign called "And Lube" to support increased access and availability of condom-compatible lubes throughout Africa. Current lubricant access across the continent is absolutely abysmal.

What especially surprised and moved Pickett was the level of enthusiasm and positivity in the room. “A lot of these people come from countries that have seriously troubling environments and where advancing HIV prevention and advocacy is met with extreme homophobia. So I thought that a lot of the discussion would be on the challenges and obstacles-- I mean, so many of the countries we were focusing on are settings where you can’t even think of doing a microbicide trial, let alone discussing sexuality openly without worrying for your safety – yet the participants didn’t get stuck on these negatives. These are men and women who are brave and strong and are committed to fighting for better health and civil rights for the people in their country. It was extraordinarily fulfilling to witness their passion and energy first hand; to see them standing up and doing this work despite the numerous challenges and obstacles in their way.”

Dr. Ian McGowan, co-principal investigator of the Microbicide Trials Network (MTN) attended the meeting, presenting the latest in rectal microbicide science. He also addressed some of the questions regarding the recent closure of the VOICE trial’s study arm testing tenofovir gel. The decision was made due to futility – while tenofovir gel was found to be safe, the trial was not able to prove the gel worked to prevent HIV. See the statement from the MTN for more information. Previously the trial had to drop its tenofovir tablet arm due to futility as well. The Truvada tablet arm in the trial is continuing. “There was a lot of speculation in the room about why it was closed,” said Pickett. Many of the people present speculated that a lack of adherence might have been a factor, said Pickett. “But of course, it’s all speculation at this point, we don’t know what happened, and we won’t till the end of next year likely.” He added that McGowan confirmed that it is still important to move forward on both vaginal and rectal microbicide research and to keep exploring ways to create a more diversified microbicide pipeline (learn more about the microbicide pipeline here and here).

For Pickett, another big highlight was McGowan’s strong validation for Project ARM’s objectives. McGowan, a highly respected veteran in microbicides research, publicly offered MTN support for future Project ARM activities and commended the participants for their collective intellect and passion. Said Pickett, “Ian participated in many of the small break-out groups, and I think he was impressed by the high quality of thought, curiosity, and energy in the room. And to have that kind of validation from someone who is one of the key rectal microbicide researchers on the planet… it was a really big moment for us. There isn’t a doubt in my mind now that Africa is squarely on the rectal microbicide map.”

Pickett also felt that an interesting backdrop to the IRMA meeting was Hillary Clinton’s speech that formalized the Obama administration’s prioritization of LGBT rights globally, helping to bolster rights’ groups on the ground in their fight against discrimination. “At the end of the day,” said Pickett, “if people aren’t free to be who they are, wherever they are, they won’t be able to make use of any prevention technology, let alone rectal microbicides. There’s no point in having a really great microbicide on the shelf if people are not safe, and therefore unable, to access it.”

Jim Pickett is the Director of Prevention Advocacy and Gay Men's Health at the AIDS Foundation of Chicago. He is chair of IRMA (International Rectal Microbicide Advocates), and a member of the Mapping Pathways team. A full report from the Project ARM meeting in Addis, laying out a rectal microbicide research and advocacy strategy for Africa will be released at the Microbicides 2012 conference in Sydney in April 2012. Until then, find updates here.

We are so proud of you Jim!!

[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]

Meet Yaa Simpson: Another New Friendly Rectal Microbicide Advocate!

“Stigma is only dispelled by shining a brighter light on it! We have to speak life and light with our words and actions. There is enough doom and gloom to impact everyone - and that is where stigma resides. But letting people know they have options, biomedical techniques for prevention, medications, possible vaccines, gathering more evidence, integrating creative research designs, etc. are all steps in the right direction. We must expect the impossible and believe in miracles!”

Yaa Simpson is an IRMA advocate from Chicago, Illinois. She is an epidemiologist for the Chicago Department of Health and a Community Epidemiologist for TACTS (The Association of Clinical Trial Services). She loves to contribute to ideas and discussion about better research in the community, specifically HIV/STI prevention trials. She is also working towards her doctoral degree and hopes to one day conduct HIV prevention trails in Chicago.

Yaa first learned of IRMA when she was invited to a presentation on microbicides several years ago. Here she was introduced to Jim Pickett and his work with IRMA. She remembers Jim saying, “We all have opinions, like we all have booties!” She now is an active member on the listserv and enjoys IRMA’s blog and educational teleconferences.

She believes rectal microbicides are an important tool to add to the prevention technology toolbox, and acknowledges that we must develop technologies to prevent HIV spreading through any avenue, including rectally.

Her advice for IRMA is to continue to be involved with people who want to see change! “Talk to those who don’t want to hear about it and strategize with those who are looking for answers. Be diligent and be patient. And if you ever feel discouraged or overwhelmed by the stigma associated with standing up for rectal microbicides, remember what Mark Twain once said: 'Keep away from people who try to belittle your ambitions. Small people always do that, but the really great make you feel that you, too, can become great.'”

Read more bios from Friendly Rectal Microbicide Advocates.



[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]

"Magic" Pills and Potions - Hocus Pocus or Plus Plus?

IRMA chair Jim Pickett was part of a forum on PrEP in Seattle a few months ago called "The Magic Pill?" hosted by the wonderful Gay City Health Project. Here is his talk - live action AND slides - in two glorious parts!

[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]

PODCAST: The Battle Over HIV Prevention - IRMA's Jim Pickett jumps in

Last time there was a lot of fuss over a little blue pill, Bob Dole was doing Viagra ads on TV.


via Feast of Fun

Check out the podcast now.

The AIDS Healthcare Foundation launched a national ad campaign to discredit PrEP or Pre Exposure Prophylaxis, a new HIV prevention technique that involves taking Truvada (an existing HIV medication) on a daily basis.

The LA based health organization blasted this approach, saying there is no magic pill, and that it’s just a misguided attempt to put HIV negative men on unnecessary meds to enrich the fat cats in the pharmaceutical industry to the tune of $10,000 a year per patient.

Why is the leadership of the nation’s largest AIDS organization arguing against a treatment that could potentially save millions of gay men from becoming HIV positive?

Today, gay men’s health advocate, Jim Pickett, from the AIDS Foundation of Chicago (and chair of IRMA) joins us to explain the and chair of IRMAcontroversy surrounding this new treatment, and the possible reasons it may be misunderstood.

Listen to the podcast.

And that smart HIV-positive shirt Jim is wearing? Part of a cool anti-stigma campaign out of the Illinois Alliance for Sound AIDS Policy. Check it out.


[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]

It's not if, it's when: IRMA's Jim Pickett on Rectal Microbicides in Africa

Writing for  the September - December 2010 issue of Echoes, a publication of the Nigerian HIV Vaccine and Microbicide Advocacy Society, IRMA chair Jim Pickett discusses the need for rectal microbicides in Africa.

Excerpt:

Until recently, rectal microbicides have simply not been part of the HIV prevention agenda in Africa, due in part to the denial of anal sex among heterosexuals and pervasive homophobia and criminalization that has denied and vilified the existence of gay men/MSM.

IRMA diligently addresses these issues, leading efforts to put rectal microbicides on the African map. These efforts are now bearing fruit - due in no small part to the significant engagement of hundreds of African advocates across the continent and extraordinary leadership by IRMA Nigeria with Kadiri Audu, IRMA Community Vice Chair, at the helm.

Read the whole thing.

While you are there, be sure to also check out the report on a rectal microbicide training for MSMs in Abuja!

[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]